bioRxivImmunologyPreprint
Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals
Michael D. SchultziD, Davide BottaiD, Aarón Silva-SáncheziD, Isabella R. CheatwoodiD, Davies KalangeiD, Sarah M. TerapaneiD, Aaron C. K. LucanderiD, Fen ZhouiD, Jobaida AktheriD, Guang YangiD, Mary E. Cockerham, William O. Stover, John A. HalliD, Dinesh Kumar YadaviD, Douglas FoxiD, Francisco de Borja Pérez DomíngueziD, Sixto Manuel LealiD, Jeremy B. FooteiD, Kevin S. HarrodiD, Troy D. RandalliD, Adrian E. Rice, Elizabeth Susan Gabitzsch, Frances E. LundiD
Abstract
Systemically administered influenza vaccines provide strain-limited protection, while influenza infection of the respiratory epithelium supports development of lung resident memory B and T cells and more broadly reactive antibody responses. To test whether local antigen delivery is critical for establishing broad immunity, we directly compared respiratory tract and systemic delivery of influenza antigens to mice and hamsters using a replication-deficient adenovirus serotype 5 vector (Ad5[E1-,E2b-,E3-]). Both immunization routes elicited antibody responses in the lower respiratory tract and antigen-specific B and T cells in the draining lymph node. However, only intranasal immunization established lung-resident memory B and T cells, induced IgA responses in the upper respiratory tract directly at the site of viral entry and supported generation of IgA and IgG antibodies that bound antigenically drifted and distantly related influenza strains, including those of avian origin. Intranasal immunization accelerated viral clearance following heterologous virus challenge and was associated with limited pulmonary inflammation and fibrosis. Thus, intranasal immunization with the immunologically stealthy Ad5[E1-,E2b-,E3-] platform supports respiratory and systemic immunity to divergent influenza strains in the absence of overt lung immunopathology, suggesting that local antigen delivery may be key to development of more broadly protective "universal" flu vaccines.
- organism: mouse
- organism: rat
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Local B-cell immunity and durable memory following live-attenuated influenza intranasal vaccination of humans
Hannah D. Stacey, Lucas Garin-Ortega, … Shane Crotty·bioRxiv·Jul 14, 2025
- Intranasal administration of split-inactivated influenza virus vaccine mixed with a novel adjuvant elicits protective antibodies against seasonal influenza viruses.
Michael A. Carlock, Katherine Lynn Cupo, Ted M. Ross·bioRxiv·Oct 23, 2025
- Intranasal adenovirus type 5 influenza vaccination enhances milk antibody responses and passive transfer to neonatal ferrets
Lauren Stewart Stafford, Pari H. Baker, … Stephanie N. Langel·bioRxiv·Oct 1, 2026
- A locally administered single cycle influenza vaccine expressing a non-fusogenic stabilised haemagglutinin stimulates strong T-cell and neutralising antibody immunity
H. Sadler, P. Rijal, … A. R. Townsend·bioRxiv·Mar 1, 2024
- Intranasal hemagglutinin protein boosters induce robust mucosal immunity and cross-protection against influenza A viral challenge
Miyu Moriyama, Gisele Regina Rodrigues, … Akiko Iwasaki·Proceedings of the National Academy of SciencesPeer-reviewed·Sep 24, 2025
- An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets
J. Park, S. Fong, … J. K. Taubenberger·bioRxiv·Sep 10, 2021